A manufacturer’s clinical claim is a statement a company makes about its own product’s performance, safety, or benefits. Independent laboratory validation is when a third-party testing body verifies those claims through controlled testing. The key difference is that one originates from a party with a financial interest in the product, while the other comes from an organization with no stake in the outcome. For hospital procurement teams, that distinction carries significant weight.
Unverified manufacturer claims are creating invisible risk in your procurement process
When a supplier tells you its product is stronger, safer, or more reliable than alternatives, that statement is only as trustworthy as the evidence behind it. Without independent verification, procurement teams are essentially taking a supplier’s word for it. If a device fails during a procedure because its actual performance fell short of the claimed performance, the consequences fall on the clinical team and the institution, not the manufacturer. The fix is straightforward: treat any claim that lacks third-party validation as unconfirmed, and build that requirement into your supplier evaluation criteria before a purchase decision is made.
Relying on clinical claims alone is holding back confident procurement decisions
Procurement directors are expected to make decisions that protect patients, control costs, and reduce institutional liability. When the evidence base for a device rests entirely on what the manufacturer says about it, that confidence is hard to justify. Independent laboratory testing provides the kind of objective, reproducible data that can be documented in procurement records, cited in clinical governance reviews, and defended if a device-related incident is ever investigated. Without it, even a well-intentioned purchasing decision rests on shaky ground. The actionable shift is to ask, at the start of every supplier conversation, which specific claims have been tested externally and by whom.
What is a manufacturer’s clinical claim in medical devices?
A manufacturer’s clinical claim is any statement made by a device company asserting that its product performs in a specific way, meets a certain safety threshold, or delivers a defined clinical benefit. These claims appear in product brochures, sales materials, and regulatory submissions. They are produced by the manufacturer and reflect the company’s own testing, design intent, or internal data.
Clinical claims can range from broad statements like “patient-friendly design” to specific performance assertions like “reduced risk of tissue trauma.” Some claims are supported by internal testing data, others by clinical observations gathered during product development, and some are based on design rationale rather than controlled testing.
The challenge for procurement teams is that not all claims are created equal. A claim backed by a controlled study carried out with clinical partners is meaningfully different from a claim based on design intent or user feedback. Without knowing what evidence supports a claim, it is difficult to assess how much confidence to place in it.
What is independent laboratory validation, and how does it work?
Independent laboratory validation is the process by which a third-party testing organization, with no financial relationship to the manufacturer, evaluates a medical device against defined performance or safety criteria. The testing body applies standardized methods, documents results objectively, and issues a report that reflects actual measured performance rather than claimed performance.
In practice, this typically involves the manufacturer submitting a device to an accredited laboratory. The laboratory applies a defined test protocol, which may assess mechanical strength, material integrity, functional performance, or other relevant parameters depending on the device type. Results are recorded, and the laboratory issues findings based solely on what the testing revealed.
The value of this process lies in its independence. Because the testing organization has no interest in a favorable outcome, the results carry a credibility that internal testing cannot match. Accredited laboratories also follow standardized protocols, which means results can be compared across different products tested under the same conditions.
For hospital procurement, a device that has undergone independent laboratory validation comes with a verifiable evidence base. The testing institution, the protocol used, and the results obtained can all be examined and confirmed.
What’s the difference between a clinical claim and lab-validated data?
The core difference is the source and verification of the evidence. A clinical claim originates from the manufacturer and reflects what the company asserts about its product. Lab-validated data originates from an independent testing organization and reflects what controlled testing actually demonstrated. One is a statement of intent or belief; the other is a documented, reproducible result.
A manufacturer might claim its product is “the strongest on the market.” That statement describes a belief or a competitive positioning. Lab-validated data, by contrast, would show the specific force applied during testing, the conditions under which the test was conducted, and the outcome observed. The claim and the data may point in the same direction, but only the validated data gives a procurement team something concrete to evaluate.
This distinction also matters for liability. If a device fails and an institution relied on a manufacturer’s unverified claim when making the purchase decision, that creates a different accountability picture than if the institution relied on independently validated test results. Lab-validated data provides a documented, defensible basis for procurement choices.
Why does independent validation matter for hospital procurement?
Independent validation matters for hospital procurement because it shifts the evidence base from a party with a commercial interest to a neutral third party. It gives procurement teams objective data to compare products, reduces the risk of purchasing decisions based on marketing rather than performance, and provides a defensible record if a device’s performance is ever questioned.
Procurement directors are responsible for decisions that affect patient safety and institutional risk. A product that has been independently validated gives clinical staff and administrators greater confidence that what is described in the product literature reflects real-world performance. That confidence is not just a comfort; it is part of sound clinical governance.
Independent validation also supports standardization. When a hospital system is evaluating whether to adopt a single product across multiple departments or sites, validated performance data makes it easier to justify that decision at multiple levels of the organization, from clinical leads to finance committees.
How can procurement teams evaluate the strength of a medical device claim?
Procurement teams can evaluate the strength of a medical device claim by asking three questions: who generated the evidence, how was it generated, and can it be independently verified? A claim backed by an accredited third-party laboratory using a documented protocol is stronger than a claim based on internal testing or user surveys alone.
A useful framework for assessing claim strength:
- Source: Was the evidence produced by the manufacturer, a clinical partner, or an independent accredited laboratory?
- Method: Was a standardized test protocol used, and is that protocol documented and available?
- Reproducibility: Could the test be repeated by another laboratory and produce comparable results?
- Specificity: Does the claim name a measurable outcome, or is it a general assertion without defined parameters?
Applying this framework consistently across supplier evaluations helps procurement teams move past marketing language and focus on what the evidence actually supports. It also creates a comparable basis for evaluating competing products, which is useful when a procurement decision involves multiple suppliers making similar claims.
What questions should you ask a supplier about product testing?
When evaluating a medical device supplier, ask directly: which of your claims have been tested by an independent laboratory, which laboratory conducted the testing, and can you provide the test report? These three questions quickly reveal whether a supplier’s claims rest on verified data or on internal assertions.
Beyond those core questions, a thorough supplier evaluation should also explore:
- What specific test protocols were used, and are they recognized by a national or international standards body?
- When was the testing conducted, and does it reflect the current version of the product?
- Were any claims revised or withdrawn following testing?
A supplier that can answer these questions clearly, and provide documentation to support its answers, is demonstrating a level of transparency that reflects well on the reliability of its product. A supplier that deflects, provides only internal test summaries, or cannot name the testing organization warrants closer scrutiny before any purchasing commitment is made.
It is also worth asking whether the testing covered edge-case performance, not just standard use conditions. A device that performs well under typical operating conditions but has not been tested under stress or unusual loads may present risks that are not visible from standard claims alone.
How Bridea Medical approaches independent validation
We believe that claims about product performance should be backed by evidence that procurement teams can actually examine. That is why we submitted the Orchid Specula to the NHS Surgical Materials Testing Laboratory (SMTL) in Wales, one of the UK’s recognized independent testing bodies for medical devices. The SMTL confirmed the Orchid Specula as the first speculum to pass its testing with a safety rating of 1,020 newtons of dynamic loading force, making it the first speculum it had ever classified as unbreakable. That result is not a marketing claim. It is a documented finding from an independent laboratory.
For procurement teams evaluating speculum options, this means:
- The reliability claim is backed by a named, accredited third-party institution
- The test results are specific, measurable, and documented
- The product is currently used by 90% of Dutch hospitals and is listed on NHS frameworks in the UK
If you are reviewing your current speculum supplier or building a procurement case for a product switch, we are happy to share our test documentation and product specifications. Visit our website to learn more, or explore the full Orchid Specula advantages and available speculum versions to find the right fit for your clinical setting.
Related Articles
- How Does Speculum Rattling During Procedures Affect Patient Anxiety Levels?
- What Is HyFoSy And What Speculum Features Does It Require?
- Can A Well-Designed Speculum Reduce The Need For Repeat Examinations Due To Poor Visualization?
- How can ergonomic medical devices reduce practitioner fatigue and injury?
- Relaxation Techniques to Use Before and During Pelvic Examinations
This content was generated with the help of AI and it may contain mistakes